Gastroenterology Research and Practice
Volume 2018 (2018), Article ID 6270514, 8 pages
https://doi.org/10.1155/2018/6270514

Research Article

High Visceral to Subcutaneous Fat Ratio Is Associated with Increased Postoperative Inflammatory Response after Colorectal Resection in Inflammatory Bowel Disease

Yao Wei,¹ Feng Zhu,² Jianfeng Gong,² Jianbo Yang,² Tenghui Zhang,² Lili Gu,² Weiming Zhu,² Zhen Guo,² Yi Li,² Ning Li,² and Jieshou Li²

¹Department of Emergency and Critical Care Medicine, The First Affiliated Hospital of Soochow University, Pinghai Road 900, Suzhou 215031, China
²Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, East Zhongshan Road 305, Nanjing 210002, China

Correspondence should be addressed to Lili Gu; drgulili@163.com

Received 24 October 2017; Revised 16 December 2017; Accepted 22 January 2018; Published 3 April 2018

Academic Editor: Gianluca Pellino

Copyright © 2018 Yao Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Aim. Excessive postoperative inflammatory response, which is characterized by overproduction of cytokines, often leads to complications after colorectal surgery. However, the impact of body composition on postoperative inflammatory response is largely unknown. The aim of this study is to elucidate whether body fat amount and its distribution affects postoperative inflammation after colorectal surgery in IBD patients. Methods. Eighty-six patients undergoing colorectal resection for IBD from June 2014 to Jan 2017 were enrolled. Abdominal CT images within one week prior to surgery were assessed for visceral fat, subcutaneous fat, and muscle mass. Postoperative inflammatory response was evaluated using serum CRP, PCT, and IL-6 levels on postoperative days 1, 3, and 5. Univariate analysis was conducted to identify risk factors for infectious complications. The correlation between body composition and postoperative plasma concentration of inflammatory markers was analyzed using a linear regression model. ROC curve was applied to analyze the effect of different body composition parameters on postoperative infectious complications and to determine the relationship between inflammatory markers and infectious complications. Results. Neither volume of fat or muscle was related to postoperative plasma concentrations of CRP, IL-6, and PCT. However, visceral to subcutaneous fat ratio was associated with PCT levels on postoperative days (POD) 1, 3, and 5, with the highest regression coefficient on POD1 (; 95% CI, 0.089–0.631; ). Body composition did not predict postoperative infectious complications, while CRP on POD 3 was predictive of infectious complications. Conclusion. Increased visceral to subcutaneous fat ratio was associated with postoperative inflammatory response in IBD patients undergoing colorectal resection. This may partly explain the increased incidence of postoperative complications in patients with visceral obesity.

1. Introduction

Elevated postoperative inflammatory response is common after colorectal resection, increasing morbidity by causing postoperative infectious complications and prolonging length of stay. Different measures have been proposed to ameliorate this situation. For example, preoperative administration of dexamethasone has been proved to reduce postoperative inflammatory response after surgery for colorectal cancer [1]. A phase II randomized study found that postoperative ghrelin administration is effective in inhibiting inflammatory markers and postoperative pulmonary complications after esophagostomy [2]. Another study comparing different surgical and analgesic techniques showed that open surgery has a greater impact on postoperative inflammatory response than laparoscopic surgery, while no significant difference was detected between epidural and intravenous analgesia [3].

The relationship between body composition and postoperative inflammatory response has drawn much attention recently. Generally, the human body consists of fat-free mass (FFM), visceral fat mass (VFM), and subcutaneous fat mass (SFM). Reisinger et al. [4] reported that sarcopenia, characterized by loss of skeletal muscle mass, is associated with increased postoperative inflammatory response after colorectal surgery. However, the impact of body fat composition on surgical outcome is largely unknown.

Visceral adipose tissue, largely distributed in the abdominal cavity, shows high hormonal and metabolic activities via secretion of various proinflammatory cytokines such as TNF-α and IL-6. Previous study showed that abdominally obese patients with excess visceral adipose tissue have elevated IL-6 and TNF-α levels and reduced adiponectin levels [5, 6]. In the case of IBD patients, Peyrin-Biroulet et al. [7] proved that mesenteric fat was an extrahepatic source of C-reactive protein (CRP) in Crohn’s disease (CD). Recent studies also found that fat subtype and distribution can predict postoperative infectious complications after bowel resection for CD, and visceral fat is associated with high risk of postoperative recurrence in CD [8, 9]. Similarly, another study also found excessive visceral fat to be an independent risk factor for both pancreas-related infection and anastomotic leak following gastrostomy [10].

Based on the aforementioned facts, we proposed a hypothesis that patients with different adipose amounts and compositions may have varied postoperative inflammatory responses. Therefore, the aim of this study was to find out if body fat composition is associated with postoperative inflammatory response in IBD patients.

2. Methods

2.1. Study Subjects

This was a retrospective study approved by the Ethical Committee of Jinling Hospital. Consecutive patients with IBD who underwent colorectal resection at Jingling Hospital from June 2014 to Jan 2017 were included in this study. Subject selection criteria included (1) patients aged 18–65 years, (2) patients undergoing colonic or rectal resection for Crohn’s disease or ulcerative colitis, and (3) availability of a CT scan of the abdomen within 7 days prior to abdominal surgery. Exclusion criteria were as follows: (1) previous history of abdominal surgery; (2) unavailable inflammatory markers on postoperative days (POD) 1, 3, and 5; and (3) preoperative systematic inflammatory response syndrome (SIRS), manifested by two or more of the following conditions:

(a)Temperature > 38°C or <36°C(b)Heart rate > 90 beats per minute(c)Respiratory rate > 20 breaths per minute or PaCO₂ < 32 mmHg(d)White blood cell count > 12,000/cu mm, <4000/cu mm, or >10% immature (band) forms [11]

2.2. Assessment of Body Fat Composition

CT data were obtained from the PACS (Picture Archiving and Communication Systems) of the patients. CT images obtained within 7 days before surgery represent the amount of muscle and subtype of body fat status at the time of surgery. A single cross-sectional CT image of a 3 mm thick slice at the level of L3 was obtained with the subject at supine position. Muscle, subcutaneous fat, and visceral fat were measured in square centimeters on the basis of the pixel count as previously described [12]. Briefly, the “Magic Wand” tool within Photoshop (Adobe Systems, San Jose, CA) was used to outline and measure the muscle, subcutaneous fat, and visceral fat in each stored digital image [13, 14].

2.3. Measurement of Clinical Parameters

Blood samples were collected regularly on the morning preoperatively and on POD1, POD3, and POD5. CRP, IL-6, alb, and PCT concentrations were measured by the laboratory department and collected from the database. Demographic information such as gender, age, and body mass index (BMI) were retrieved from medical records. Intraoperative data including operative site, operation time, and estimated blood loss were collected in operation charts. Preoperative use of 5-ASA and steroids was defined as 4 weeks before surgery, and preoperative use of immunomodulators or biologics (azathioprine, 6-mercaptopurine, or infliximab administered) was defined as 8 weeks before surgery. Patients’ history was reviewed for diagnosis, postoperative length of stay, and complications. Postoperative infectious complications were classified into surgical site infection (SSI) and remote site infection (RSI) [15–18]. SSI can be further divided into incisional (wound infection) and others (anastomotic leak and intra-abdominal collection). RSI includes urinary tract infection, septicemia, antibiotic enterocolitis, and central line infection [19]. But Clostridium difficile colitis and pneumonia were not included in postoperative infectious complications.

2.4. Statistics

Data for demographic characteristics are expressed as mean ± SD or median (range), depending on whether it is normally distributed according to the Levene test. Univariate analysis was conducted to identify any risk factors of postoperative infectious complications. Any factors with a were further assembled for logistic regression analysis after validating the absence of multicollinearity. To evaluate whether a different body composition is associated with inflammatory response after colorectal surgery, linear regression models were applied after testing the sample for linearity, independence, normality, and equal variance. Different body composition parameters such as the skeletal muscle area (SMA), visceral fat area (VFA), subcutaneous fat area (SFA), and ratio of VFA/SFA were screened. The regression coefficient β was calculated, and a value of <0.05 was considered as statistically significant. ROC curves were drawn to analyze the effect of different body composition parameters and inflammatory markers on postoperative infectious complications. All analyses were conducted using SPSS version 20.0 (SPSS Inc., an IBM company, Chicago, IL).

3. Results

3.1. Patients’ Characteristics

A total of 527 IBD patients underwent colorectal surgery in our center from June 2014 to Jan 2017. 126 patients met the inclusion criteria. 40 patients were excluded subsequently (18 without accessible results of inflammatory markers, 11 with previous abdominal surgery, 8 with preoperative SIRS, and 3 with preoperative abdominal abscess). The selection process was demonstrated in Figure 1. Finally, 86 patients were enrolled in our study. General characteristics and perioperative parameters of patients were listed in Table 1. 51 (59.3%) patients were male. The average age was 36.2 (14.0). The mean BMI was 18.2 ± 2.83 kg/m². The mean VFA values in males and females were 62.30 ± 39.0 cm² and 74.10 ± 31.80 cm², respectively (). The mean SFA values in males and females were 77.0 ± 52.40 cm² and 141.80 ± 69.90 cm², respectively (). The ratio of VFA to SFA was defined as mesenteric fat index (MFI), and males had higher MFI compared to females (0.74 ± 0.33 versus 0.51 ± 0.23, ).

Figure 1: Flow chart demonstrating the selection process of the patients.

Table 1: Basic characteristics of the patients ().

With infectious complications ()
Without infectious complications ()

Age
36.7 (13.3)
35.9 (12.9)
0.628a

Sex (male : female)
18 : 11
33 : 24
0.710b

Muscle cross section area
136.1 (35.4)
132.3 (42.5)
0.679a

Subcutaneous fat area (cm²)
106.1 (68.9)
102.0 (67.7)
0.793a

Visceral fat area (cm²)
67.7 (34.7)
66.7 (37.7)
0.904a

Mesenteric fat index (MFI)
2.18 (2.49)
1.98 (1.91)
0.683a

BMI (kg/m²)
18.6 (2.6)
17.9 (2.9)
0.314a

Preoperative albumin (g/L)†
34.8
38.2
<0.001a

Preoperative medication

    5-ASA
14
23
0.483b

    Immunomodulators
14
18
0.130b

    Glucocorticoids
11
10
0.037b

    Biologics
1
4
0.659b

Diagnosis

    Crohn’s disease
20
44
—

    Ulcerative colitis
12
10
0.001b

Surgical site

    Ileocecal/right colectomy
13
29
—

    Transverse colectomy
1
3
—

    Left colectomy
4
6
—

    Sigmoid/rectal resection
2
6
—

    Total colectomy
12
10
0.001c

Surgical technique (laparoscopic : open surgery)
11 : 18
17 : 40
0.448b

Estimated blood loss (mL), median (range)
101.3 (10–300)
101.3 (10–300)
0.164d

Operative time (min), mean (SD)
182.6 (58.2)
221.0 (68.0)
0.008a

Length of stay (day), median (range)
14.3 (7–44)
8.8 (4–22)
<0.001d

Postoperative complications (Clavien-Dindo classification)

    I
11
—
—

    II
22
—
—

    III
2
—
—

    IV or above
0
—
—

Data presented as mean (SD) or median (range). Data were calculated using aStudent’s t-test, b test, cFisher’s exact test, and dMann–Whitney U test. †Preoperative albumin level was not recorded for 4 patients.

Among these 86 patients, 64 (74.4%) patients were diagnosed with Crohn’s disease, and 22 (25.6%) patients were diagnosed with ulcerative colitis. 42 (48.8%) patients underwent ileocecal/right colectomy, 4 (4.65%) patients underwent transverse colectomy, 10 (11.6%) patients underwent left colectomy, 8 (9.30%) patients underwent sigmoid/rectal resection, and 22 (25.6%) patients underwent total colectomy. Besides, 28 (32.6%) patients underwent laparoscopic surgery, and 58 (77.4%) patients underwent open surgery. Estimated intraoperative blood loss was 88.1 (10–300) mL. Operation time was 195.6 ± 64.0 min. Postoperative length of stay was 10.7 (4–44) day.

3.2. Postoperative Inflammatory Response

Postoperative inflammatory markers were shown in Figure 2. Generally, preoperative inflammatory markers are comparatively low (CRP 6.63 ± 1.94 mg/L, IL-6 9.86 ± 4.25 ng/L, and PCT 0.09 ± 0.28 μg/L). Both postoperative IL-6 and PCT showed a descending trajectory from POD 1 (IL-6147.02 ± 47.8 ng/L and PCT 2.30 ± 1.10 μg/L) to POD 5 (IL-6 33.87 ± 14.01 ng/L and PCT 0.30 ± 0.16 g/L), while CRP peaked on POD 3 (91.05 ± 29.80 mg/L).

(a)

(b)

(c)

Figure 2: Changes over postoperative time in C-reactive protein (a), interleukin-6 (b), and procalcitonin (c). All of the three plasma inflammatory markers increased greatly after the surgery took place. CRP had a peak on POD 3, while IL-6 and PCT decreased from POD 1 to 5. Pre: preoperative; POD x: postoperative day x.

Linear regression analysis showed that MFI had a positive correlation with PCT from POD 1 to 5, with the highest coefficient appearing on POD 3 (; 95% CI, 0.089–0.631; ). Regression coefficients β and confidence intervals are summarized in Table 2. However, BMI, SMA, SFA, and VFA alone were not related to postoperative inflammatory markers, and neither CRP nor IL-6 was correlated with MFI.

Table 2: Regression of body composition and PCT on different postoperative days.

β
95% CI

POD 1

    MFI
0.360
0.089
0.631
0.010

    Muscle area
−0.001
−0.018
0.016
0.938

    Visceral fat area
0.017
0.006
0.032
0.175

    Subcutaneous fat area
−0.013
−0.022
−0.004
0.118

POD 3

    MFI
0.131
0.023
0.239
0.018

    Muscle area
−0.001
−0.007
0.006
0.772

    Visceral fat area
0.010
0.004
0.019
0.192

    Subcutaneous fat area
−0.005
−0.009
−0.002
0.213

POD 5

    MFI
0.130
0.062
0.198
<0.001

    Muscle area
0.001
−0.002
0.003
0.644

    Visceral fat area
0.003
0.001
0.007
0.421

    Subcutaneous fat area
−0.002
−0.003
<0.001
0.271

POD x: postoperative day x; CI: confidence interval.

3.3. Postoperative Infectious Complications

Of the 86 patients, 11 had Clavien-Dindo I complications (6 with ileus and 5 with wound infection not requiring intravenous antibiotics), 22 had Clavien-Dindo II complications (14 with wound infection requiring intravenous antibiotics, 5 with pouchitis, and 3 with intra-abdominal infection), and 2 had Clavien-Dindo III complications (1 with intra-abdominal infection requiring stoma reconstruction under general anesthesia and with 1 intra-abdominal infection requiring reoperation on POD 10). A total of 29 (33.7%) patients had postoperative infectious complications (wound infection in five class I patients and in all the class II and III patients). Univariate analysis showed that preoperative albumin level, steroid use, diagnosis, surgical site, and operation time were associated with postoperative infectious complications. Table 3 shows that preoperative albumin level (, , OR 0.873, 95% CI 0.834–0.914), steroid use (, , OR 2.671, 95% CI 0.928–7.683), and operation time (, , OR 1.010, 95% CI 1.001–1.019) were associated with postoperative infectious complications. BMI of patients with and without infectious complication after surgery was 18.6 kg/m² versus 17.9 kg/m² (). Likewise, none of the body composition parameters, including BMI, MFI, VFA, and SFA, were associated with postoperative infectious complications. Furthermore, the relationship between CRP levels and the development of postoperative infectious complications in IBD patients were plotted in ROC curves (Figure 3). It demonstrated that the CRP levels on POD 3 were predictive of postoperative infectious complications, with an AUC value of 0.760 (95% CI: 0.646–0.875, ). The optimal cutoff value was 55.3 mg/L with the sensitivity being 62.1% and the specificity being 73.7%.

Table 3: Logistic regression of variables associated with postoperative infectious complications.

Factors
β
Odds ratio
95% CI

Albumin level
−0.135
0.873
0.834–0.914
<0.001

Steroid use
0.982
2.671
0.928–7.683
0.038

Total colectomy
0.229
1.257
0.370–4.274
0.714

Operation time
0.010
1.010
1.001–1.019
0.022

Figure 3: Diagnostic accuracy of inflammatory markers with regard to development of postoperative infectious complications. The AUC values were 0.708 (), 0.760 (), and 0.734 () for CRP on postoperative days (POD) 1, 3, and 5, respectively; Youden index revealed that a CRP level of >55.3 mg/L on POD 3 is predictive of postoperative complications with the sensitivity being 62.1% and the specificity being 73.7%.

4. Discussion

Surgery leads to predictable inflammatory response afterwards, causing acute phase responses initialized by production of proinflammatory cytokines including IL-1, IL-6, IL-8, and TNF-α. Such cytokines act to mobilize the innate immune system, resulting in the activation of neutrophils, macrophages, and platelets [20]. Besides, the presence of systemic inflammatory response can suppress cytotoxic immunity and may promote the development of postoperative complications [21]. Of all the commonly examined inflammatory markers, CRP and IL-6 are both useful markers representing the magnitude of postoperative inflammation [22]. Also, PCT is another effective marker of postoperative inflammatory response showing higher specificity than CRP in differentiating between inflammation and infection according to [23].

Previous articles showed variations in fat volume, and distribution may impact surgical outcomes [10, 24–28]. However, neither visceral fat mass nor subcutaneous fat mass alone can capture changes in fat distribution and overall body composition. As a result, our study found no significant correlation between them and postoperative inflammatory response.

On the other hand, visceral obesity measured by visceral fat area (VFA) and VFA/SFA ratio has been examined as a predictor of colorectal surgery outcomes [12, 28, 29]. The negative effects of visceral adipose tissue are thought to be mediated by the state of chronic inflammation associated with cytokines such as TNF-α, IL-6, and IL-8 [13].

In our study, we found that MFI reflects the composition of body fat, and an increased MFI is related to higher PCT after operations from POD1 to POD5. That is to say, the ratio of visceral fat area/subcutaneous fat area can be a predictor of inflammatory response to surgery. Surgeons can, in advance, adopt measures such as physical exercise to modify body composition to prevent severe inflammatory response after surgery. However, we found that muscle mass is not associated with increased postoperative inflammatory response, which is inconsistent with the conclusion of other studies [4, 30]. This might be caused by the insufficient sample size of our study. Besides, Stidham et al. [8] found that subcutaneous to visceral fat ratio was predictive of infectious complications, and Ding et al. [31] described the relationship between higher visceral fat and postoperative complications in Crohn’s disease. In contrast, our study found no difference in body composition between patients with infectious complications and those without, which might be caused by the inclusion of ulcerative colitis patients in our cohort and the different technique of body composition analysis applied. These conflicting findings together warrants further prospective, multicenter studies with larger sample size to elucidate the relationship between body fat and postoperative infectious complications.

Apart from MFI and other body composition parameters, we also evaluated the inflammatory biomarkers’ capacity to predict infectious complications. Mokart et al. [32] reported that serum IL-6 concentration is higher in patients undergoing a range of abdominal surgeries who develop postoperative SIRS or sepsis than in those with uneventful recovery. Raised IL-6 on postoperative day 1 predicts postoperative sepsis in patients undergoing major gastrointestinal surgery. In our study, 29 (33.7%) patients had infectious complications after surgery. ROC analysis showed that neither IL-6 nor PCT was predictive of postoperative infectious complications. This is different from the previous results and warrants more studies. A CRP level of >170 mg/L measured on POD 3 is another effective predictor of infectious complications in patients with colorectal cancer according to Platt et al. [19]. Our results in IBD patients agree with the previous study with the optimal threshold of CRP > 55.3 mg/L on POD 3 in predicting postoperative infectious complications.

Several limitations must be considered when interpreting the results of our work. First, decisions on surgical timing, preoperative optimization strategies, and surgical methods and the surgeons were not standardized among patients, introducing selection bias into the results. Second, measures such as propensity-score matching were not introduced in our study to eliminate the potential confounding variables. Third, the sample size is small and comes from a single center. Therefore, a multicenter study with a larger sample size is required to validate our findings.

Despite the limitations of a retrospective study design, these data indicate that a more detailed fat assessment may aid in the prediction of postoperative inflammatory response and infectious complications in general surgery.

Abbreviations

BMI: | Body mass index
CD: | Crohn’s disease
CI: | Confidence interval
CT: | Computed tomography
IBD: | Inflammatory bowel disease
LOS: | Length of stay
MFI: | Mesenteric fat index
SFA: | Subcutaneous fat area
VFA: | Visceral fat area
SIRS: | Systemic inflammatory response syndrome
SSI: | Surgical site infection
RSI: | Remote site infection
CRP: | C-reactive protein
IL-6: | Interleukin-6
PCT: | Procalcitonin
5-ASA: | 5-Aminosalicylic acid
PACS: | Picture Archiving and Communication Systems.

Additional Points

Statement: What Does This Paper Add to the Literature? A part of IBD patients with normal body weight could suffer from serious inflammatory response after colorectal surgery. This paper found that the ratio of visceral to subcutaneous fat affects postoperative inflammatory response in an IBD patient, and this may aid in the prediction of postoperative inflammatory response and infectious complications in general surgery.

Conflicts of Interest

The authors had no conflicts of interest.

Authors’ Contributions

Yao Wei and Feng Zhu contributed equally.

References

S. T. McSorley, C. S. Roxburgh, P. G. Horgan, and D. C. McMillan, “The impact of preoperative dexamethasone on the magnitude of the postoperative systemic inflammatory response and complications following surgery for colorectal cancer,” Annals of Surgical Oncology, vol. 24, no. 8, pp. 2104–2112, 2017.

A. Takata, S. Takiguchi, Y. Miyazaki et al., “Randomized phase II study of the anti-inflammatory effect of ghrelin during the postoperative period of esophagectomy,” Annals of Surgery, vol. 262, no. 2, pp. 230–236, 2015.

W. Siekmann, C. Eintrei, A. Magnuson et al., “Surgical and not analgesic technique affects postoperative inflammation following colorectal cancer surgery: a prospective, randomized study,” Colorectal Disease, vol. 19, no. 6, pp. O186–O195, 2017.

K. W. Reisinger, J. P. Derikx, J. L. van Vugt et al., “Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer,” Clinical Nutrition, vol. 35, no. 4, pp. 924–927, 2016.

M. Côté, P. Mauriège, J. Bergeron et al., “Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men,” The Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 3, pp. 1434–1439, 2005.

I. Lemieux, A. Pascot, D. Prud’homme et al., “Contribution of interleukin-6 and tumor necrosis factor-alpha to the elevated C-reactive protein levels found in abdominally obese men,” Obesity Research, vol. 66S, p. 9, 2001.

L. Peyrin-Biroulet, F. Gonzalez, L. Dubuquoy et al., “Mesenteric fat as a source of C reactive protein and as a target for bacterial translocation in Crohn’s disease,” Gut, vol. 61, no. 1, pp. 78–85, 2011.

R. W. Stidham, A. K. Waljee, N. M. Day et al., “Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn’s disease,” Inflammatory Bowel Diseases, vol. 21, no. 6, pp. 1–13, 2015.

Y. Li, W. Zhu, J. Gong et al., “Visceral fat area is associated with a high risk for early postoperative recurrence in Crohn’s disease,” Colorectal Disease, vol. 17, no. 3, pp. 225–234, 2015.

N. Sugisawa, M. Tokunaga, Y. Tanizawa, E. Bando, T. Kawamura, and M. Terashima, “Intra-abdominal infectious complications following gastrectomy in patients with excessive visceral fat,” Gastric Cancer, vol. 15, no. 2, pp. 206–212, 2012.

R. Bone, R. Balk, and C. L. Sprung, “ACCP/SCCM consensus conference for sepsis and organ failure,” Chest, vol. 101, no. 6, pp. 1481–1483, 1992.

T. Zhang, L. Cao, T. Cao et al., “Prevalence of sarcopenia and its impact on postoperative outcome in patients with Crohn's disease undergoing bowel resection,” JPEN Journal of Parenteral and Enteral Nutrition, vol. 41, no. 4, pp. 592–600, 2015.

K. Fearon, F. Strasser, S. D. Anker et al., “Definition and classification of cancer cachexia: an international consensus,” The Lancet Oncology, vol. 12, no. 5, pp. 489–495, 2011.

M. Quante, A. Dietrich, A. ElKhal, and S. G. Tullius, “Obesity-related immune responses and their impact on surgical outcomes,” International Journal of Obesity, vol. 39, no. 6, pp. 877–883, 2015.

L. D. Edwards, “The epidemiology of 2056 remote site infections and 1966 surgical wound infections occurring in 1865 patients: a four year study of 40,923 operations at Rush–Presbyterian–St. Luke’s Hospital, Chicago,” Annals of Surgery, vol. 184, no. 6, pp. 758–766, 1976.

C. Miki, Y. Inoue, Y. Mohri, M. Kobayashi, and M. Kusunoki, “Site-specific patterns of surgical site infections and their early indicators after elective colorectal cancer surgery,” Diseases of the Colon and Rectum, vol. 49, no. 1, pp. S45–S52, 2006.

A. Matsuda, T. Matsutani, K. Sasajima et al., “Preoperative plasma adiponectin level is a risk factor for postoperative infection following colorectal cancer surgery,” The Journal of Surgical Research, vol. 157, no. 2, pp. 227–234, 2009.

A. J. Mangram, T. C. Horan, M. L. Pearson, L. C. Silver, W. R. Jarvis, and Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee, “Guideline for prevention of surgical site infection, 1999,” American Journal of Infection Control, vol. 27, no. 2, pp. 97–134, 1999, 10196487.

J. J. Platt, M. L. Ramanathan, R. A. Crosbie et al., “C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer,” Annals of Surgical Oncology, vol. 19, no. 13, pp. 4168–4177, 2012.

S. T. McSorley, P. G. Horgan, and D. C. McMillan, “The impact of preoperative corticosteroids on the systemic inflammatory response and postoperative complications following surgery for gastrointestinal cancer: a systematic review and meta-analysis,” Critical Reviews in Oncology/Hematology, vol. 101, pp. 139–150, 2016.

S. T. McSorley, D. G. Watt, P. G. Horgan, and D. C. McMillan, “Postoperative systemic inflammatory response, complication severity, and survival following surgery for colorectal cancer,” Annals of Surgical Oncology, vol. 23, no. 9, pp. 2832–2840, 2016.

D. G. Watt, P. G. Horgan, and D. C. McMillan, “Routine clinical markers of the magnitude of the systemic inflammatory response after elective operation: a systematic review,” Surgery, vol. 157, no. 2, pp. 362–380, 2015.

M. Oberhoffer, W. Karzai, A. Meier-Hellmann, D. Bogel, J. Fassbinder, and K. Reinhart, “Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis,” Critical Care Medicine, vol. 27, no. 9, pp. 1814–1818, 1999.

F. Rieder and C. Fiocchi, “Mechanisms of tissue remodeling in inflammatory bowel disease,” Digestive Diseases, vol. 31, no. 2, pp. 186–193, 2013.

G. Malietzis, A. C. Currie, T. Athanasiou et al., “Influence of body composition profile on outcomes following colorectal cancer surgery,” The British Journal of Surgery, vol. 103, no. 5, pp. 572–580, 2016.

T. C. Hall, J. S. Stephenson, M. J. Jones et al., “Is abdominal fat distribution measured by axial CT imaging an indicator of complications and mortality in acute pancreatitis?” Journal of Gastrointestinal Surgery, vol. 19, no. 12, pp. 2126–2131, 2015.

C. H. Richards, C. S. Roxburgh, M. T. MacMillan et al., “The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer,” PLoS One, vol. 7, no. 8, article e41883, 2012.

W. Alazawi, N. Pirmadjid, R. Lahiri, and S. Bhattacharya, “Inflammatory and immune responses to surgery and their clinical impact,” Annals of Surgery, vol. 264, no. 1, pp. 73–80, 2016.

L. Martin, L. Birdsell, N. Macdonald et al., “Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index,” Journal of Clinical Oncology, vol. 31, no. 12, pp. 1539–1547, 2013.

Y. Nakashima, H. Saeki, R. Nakanishi et al., “Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer,” Annals of Surgery, vol. 4, no. 2, p. 1, 2017.

Z. Ding, X. R. Wu, E. M. Remer et al., “Association between high visceral fat area and postoperative complications in patients with Crohn’s disease following primary surgery,” Colorectal Disease, vol. 18, no. 2, pp. 163–172, 2016.

D. Mokart, M. Merlin, A. Sannini et al., “Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery,” British Journal of Anaesthesia, vol. 94, no. 6, pp. 767–773, 2005.